208 related articles for article (PubMed ID: 17655957)
1. Rapid detection of Staphylococcus aureus strains having reduced susceptibility to vancomycin using a chemiluminescence-based drug-susceptibility test.
Tajima Y; Komatsu M; Ito T; Hiramatsu K
J Microbiol Methods; 2007 Sep; 70(3):434-41. PubMed ID: 17655957
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of rapid antimicrobial susceptibility test for Staphylococcus aureus by chemiluminescent assay and its application for screening of beta-lactam antibiotic induced vancomycin-resistant MRSA].
Nagasawa Z; Nakashima Y; Oho M; Kusaba K; Manome I; Nagayama A
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2008; 19(1-2):7-15. PubMed ID: 19583457
[TBL] [Abstract][Full Text] [Related]
3. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
Pillai SK; Wennersten C; Venkataraman L; Eliopoulos GM; Moellering RC; Karchmer AW
Clin Infect Dis; 2009 Oct; 49(8):1169-74. PubMed ID: 19769538
[TBL] [Abstract][Full Text] [Related]
4. The activity of daptomycin against wild-type Staphylococcus aureus and strains with reduced susceptibility to vancomycin.
Sader HS; Jones RN
Clin Infect Dis; 2006 Sep; 43(6):798-9; author reply 799-800. PubMed ID: 16912964
[No Abstract] [Full Text] [Related]
5. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides.
Walsh TR; Bolmström A; Qwärnström A; Ho P; Wootton M; Howe RA; MacGowan AP; Diekema D
J Clin Microbiol; 2001 Jul; 39(7):2439-44. PubMed ID: 11427551
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides.
Leonard SN; Rossi KL; Newton KL; Rybak MJ
J Antimicrob Chemother; 2009 Mar; 63(3):489-92. PubMed ID: 19136530
[TBL] [Abstract][Full Text] [Related]
7. Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains.
Jones RN
Clin Infect Dis; 2006 Jan; 42 Suppl 1():S13-24. PubMed ID: 16323115
[TBL] [Abstract][Full Text] [Related]
8. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus.
Tenover FC; Moellering RC
Clin Infect Dis; 2007 May; 44(9):1208-15. PubMed ID: 17407040
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of laboratory-generated vancomycin intermediate resistant Staphylococcus aureus strains.
Bhateja P; Purnapatre K; Dube S; Fatma T; Rattan A
Int J Antimicrob Agents; 2006 Mar; 27(3):201-11. PubMed ID: 16417988
[TBL] [Abstract][Full Text] [Related]
10. Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.
Pillai SK; Gold HS; Sakoulas G; Wennersten C; Moellering RC; Eliopoulos GM
Antimicrob Agents Chemother; 2007 Jun; 51(6):2223-5. PubMed ID: 17404001
[TBL] [Abstract][Full Text] [Related]
11. The need for accuracy in performing vancomycin intermediate resistant Staphylococcus aureus (VISA) and hetero--VISA detection methods.
Wootton M
Int J Antimicrob Agents; 2006 Dec; 28(6):586. PubMed ID: 17049817
[No Abstract] [Full Text] [Related]
12. Practical strategies for detecting and confirming vancomycin-intermediate Staphylococcus aureus: a tertiary-care hospital laboratory's experience.
Marlowe EM; Cohen MD; Hindler JF; Ward KW; Bruckner DA
J Clin Microbiol; 2001 Jul; 39(7):2637-9. PubMed ID: 11427582
[TBL] [Abstract][Full Text] [Related]
13. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
Appelbaum PC
Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634
[TBL] [Abstract][Full Text] [Related]
14. Clinical isolates of Staphylococcus aureus from 1987 and 1989 demonstrating heterogeneous resistance to vancomycin and teicoplanin.
Rybak MJ; Cha R; Cheung CM; Meka VG; Kaatz GW
Diagn Microbiol Infect Dis; 2005 Feb; 51(2):119-25. PubMed ID: 15698717
[TBL] [Abstract][Full Text] [Related]
15. Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin.
Tsuji BT; Rybak MJ
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):73-7. PubMed ID: 16368477
[TBL] [Abstract][Full Text] [Related]
16. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.
Woods CW; Cheng AC; Fowler VG; Moorefield M; Frederick J; Sakoulas G; Meka VG; Tenover FC; Zwadyk P; Wilson KH
Clin Infect Dis; 2004 Apr; 38(8):1188-91. PubMed ID: 15095227
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
Hoşgör Limoncu M; Ermertcan S; Taşli H; Kurutepe S
Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069
[TBL] [Abstract][Full Text] [Related]
18. Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function.
Rose WE; Rybak MJ; Tsuji BT; Kaatz GW; Sakoulas G
J Antimicrob Chemother; 2007 Jun; 59(6):1190-3. PubMed ID: 17434881
[TBL] [Abstract][Full Text] [Related]
19. An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus.
Patel JB; Jevitt LA; Hageman J; McDonald LC; Tenover FC
Clin Infect Dis; 2006 Jun; 42(11):1652-3. PubMed ID: 16652325
[No Abstract] [Full Text] [Related]
20. [Vancomycin-resistant Staphylococcus aureus].
Rodríguez CA; Vesga O
Biomedica; 2005 Dec; 25(4):575-87. PubMed ID: 16433184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
